Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice
- PMID: 33470505
- PMCID: PMC7884042
- DOI: 10.1111/acel.13296
Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice
Abstract
Cellular senescence is characterized by an irreversible cell cycle arrest and a pro-inflammatory senescence-associated secretory phenotype (SASP), which is a major contributor to aging and age-related diseases. Clearance of senescent cells has been shown to improve brain function in mouse models of neurodegenerative diseases. However, it is still unknown whether senescent cell clearance alleviates cognitive dysfunction during the aging process. To investigate this, we first conducted single-nuclei and single-cell RNA-seq in the hippocampus from young and aged mice. We observed an age-dependent increase in p16Ink4a senescent cells, which was more pronounced in microglia and oligodendrocyte progenitor cells and characterized by a SASP. We then aged INK-ATTAC mice, in which p16Ink4a -positive senescent cells can be genetically eliminated upon treatment with the drug AP20187 and treated them either with AP20187 or with the senolytic cocktail Dasatinib and Quercetin. We observed that both strategies resulted in a decrease in p16Ink4a exclusively in the microglial population, resulting in reduced microglial activation and reduced expression of SASP factors. Importantly, both approaches significantly improved cognitive function in aged mice. Our data provide proof-of-concept for senolytic interventions' being a potential therapeutic avenue for alleviating age-associated cognitive impairment.
Keywords: SASP; aging; brain; cognition; memory; neurodegeneration; senescence; senolytic; telomeres.
© 2021 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Conflict of interest statement
Patents on
Figures
Similar articles
-
Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.Front Endocrinol (Lausanne). 2022 Mar 31;13:869414. doi: 10.3389/fendo.2022.869414. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432205 Free PMC article. Review.
-
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline.Nature. 2018 Oct;562(7728):578-582. doi: 10.1038/s41586-018-0543-y. Epub 2018 Sep 19. Nature. 2018. PMID: 30232451 Free PMC article.
-
Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy.J Am Soc Nephrol. 2021 Aug;32(8):1987-2004. doi: 10.1681/ASN.2020091373. Epub 2021 Jun 16. J Am Soc Nephrol. 2021. PMID: 34135081 Free PMC article.
-
Targeted clearance of p21- but not p16-positive senescent cells prevents radiation-induced osteoporosis and increased marrow adiposity.Aging Cell. 2022 May;21(5):e13602. doi: 10.1111/acel.13602. Epub 2022 Apr 1. Aging Cell. 2022. PMID: 35363946 Free PMC article.
-
Cellular Senescence: Mechanisms, Morphology, and Mouse Models.Vet Pathol. 2020 Nov;57(6):747-757. doi: 10.1177/0300985820943841. Epub 2020 Aug 3. Vet Pathol. 2020. PMID: 32744147 Review.
Cited by
-
Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates.Heliyon. 2024 Aug 17;10(16):e36483. doi: 10.1016/j.heliyon.2024.e36483. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39253182 Free PMC article.
-
Inflammatory aspects of Alzheimer's disease.Acta Neuropathol. 2024 Aug 28;148(1):31. doi: 10.1007/s00401-024-02790-2. Acta Neuropathol. 2024. PMID: 39196440 Review.
-
A nutrigeroscience approach: Dietary macronutrients and cellular senescence.Cell Metab. 2024 Sep 3;36(9):1914-1944. doi: 10.1016/j.cmet.2024.07.025. Epub 2024 Aug 22. Cell Metab. 2024. PMID: 39178854 Review.
-
Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms.J Bone Oncol. 2024 Jul 5;47:100620. doi: 10.1016/j.jbo.2024.100620. eCollection 2024 Aug. J Bone Oncol. 2024. PMID: 39072049 Free PMC article.
-
SenNet recommendations for detecting senescent cells in different tissues.Nat Rev Mol Cell Biol. 2024 Jun 3. doi: 10.1038/s41580-024-00738-8. Online ahead of print. Nat Rev Mol Cell Biol. 2024. PMID: 38831121 Review.
References
-
- Acosta, J. C. , Banito, A. , Wuestefeld, T. , Georgilis, A. , Janich, P. , Morton, J. P. , Athineos, D. , Kang, T.‐W. , Lasitschka, F. , Andrulis, M. , Pascual, G. , Morris, K. J. , Khan, S. , Jin, H. , Dharmalingam, G. , Snijders, A. P. , Carroll, T. , Capper, D. , Pritchard, C. , … Gil, J. (2013). A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nature Cell Biology, 15, 978–990. 10.1038/ncb2784 - DOI - PMC - PubMed
-
- Aguayo‐Mazzucato, C. , Andle, J. , Lee, Jr., T. B. , Midha, A. , Talemal, L. , Chipashvili, V. , Hollister‐Lock, J. , Van Deursen, J. , Weir, G. , & Bonner‐Weir, S. (2019). Acceleration of beta cell aging determines diabetes and senolysis improves disease outcomes. Cell Metabolism, 30, 129–142e124. 10.1016/j.cmet.2019.05.006 - DOI - PMC - PubMed
-
- Baker, D. J. , Childs, B. G. , Durik, M. , Wijers, M. E. , Sieben, C. J. , Zhong, J. , A. Saltness, R. , Jeganathan, K. B. , Verzosa, G. C. , Pezeshki, A. , Khazaie, K. , Miller, J. D. , & van Deursen, J. M. (2016). Naturally occurring p16Ink4a‐positive cells shorten healthy lifespan. Nature, 530, 184–189. 10.1038/nature16932 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- BB/H022384/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- MR/P020941/1/MRC_/Medical Research Council/United Kingdom
- AG050582-01A1/AG/NIA NIH HHS/United States
- AG013925/AG/NIA NIH HHS/United States
- AG056053/NH/NIH HHS/United States
- BB/K017314/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- T32 AG041688/AG/NIA NIH HHS/United States
- U24 AG056053/AG/NIA NIH HHS/United States
- P30 AG050886/AG/NIA NIH HHS/United States
- R01 AG068182/AG/NIA NIH HHS/United States
- UL1 TR002377/TR/NCATS NIH HHS/United States
- P20 GM109035/GM/NIGMS NIH HHS/United States
- R37 AG013925/AG/NIA NIH HHS/United States
- R01 AG069048/AG/NIA NIH HHS/United States
- P01 AG062413/AG/NIA NIH HHS/United States
- AG050886/NH/NIH HHS/United States
- UL1 TR0002377/TR/NCATS NIH HHS/United States
- R01 AG050582/AG/NIA NIH HHS/United States
- R56 AG050582/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical